Status:
RECRUITING
Comparing the Impact of Four Types of Meditation Practices for Relaxation in Cancer Survivors
Lead Sponsor:
City of Hope Medical Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial compares the impact of four types of meditation practices, breathing only, focused attention only, mindfulness only, and breathing, focused attention and mindfulness combined, for ...
Detailed Description
PRIMARY OBJECTIVE: I. Assess the feasibility to attend and complete the meditation program as scheduled (combined arms) within six weeks. EXPLORATORY OBJECTIVES: I. Assess the ability of breathing,...
Eligibility Criteria
Inclusion
- Documented written informed consent of the participant
- Age: ≥ 18 years
- Ability to understand and fluently speak English or Spanish
- No previous training in mind-body relaxation techniques including meditation, yoga, tai chi, qigong, guided imagery, mindfulness-based stress reduction, hypnosis, or cognitive behavior therapy, that exceeds 3 hours. Additionally, no regular practice of mind-body relaxation techniques, or formal experience with mind-body relaxation techniques within the past 12 months
- Visual Analog Scale (VAS) anxiety score of \> 3 from a range from 0 to 10. A "0" means the lowest anxiety score and a "10" means the highest anxiety score
- Long-term cancer survivors who received surgery to treat their cancer ( \> 6 months since last treatment) with no history of chemotherapy, radiation therapy, or other systemic therapy (e.g., hormonal therapy) and/or have completely recovered from surgery OR patients identified as having pre-cancerous lesions that have been surgically treated (e.g., colon polyp that has been removed)
- Willingness to:
- Provide salivary alpha-amylase sample
- Complete stress tests and study questionnaires
- Be monitored with a Bispectral Index (BIS) device
Exclusion
- Inability to complete study required time and procedures as outlined in the study procedures section of the protocol
- Must not have had previous serious illnesses that affect neurological functioning such as strokes, heart attacks, Parkinson disease, etc
- Ongoing active psychiatric condition, depressive/bi-polar related disorders, anxiety, psychosis disorders, or substance use that may interfere with the study including panic disorder, major depression, schizophrenia, and bipolar disease
- Active cancer
- Cancer survivors who have received chemotherapy, radiation therapy, or any other systemic treatment (e.g., hormonal therapy)
- Women who are pregnant
Key Trial Info
Start Date :
June 17 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 17 2026
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT06500377
Start Date
June 17 2024
End Date
June 17 2026
Last Update
July 11 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
City of Hope Medical Center
Duarte, California, United States, 91010
2
City of Hope at Irvine Lennar
Irvine, California, United States, 92618